Think.Health is a venture capital firm that invests as a boutique risk-taker in healthcare ventures, focusing on innovations and disruptive business models within digital healthcare, medical technologies, and health service providers. The firm typically targets early-stage and growth opportunities with investments ranging from €500k to €10m.
50% of their portfolio is in Consumer. Their most common stage is series-c (50% of deals).
Portfolio
2
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Robeauté | Series B | $27.2M | Jan 2025 |
 Inflammatix | Series C | $32M | Jan 2020 |
Top Co-Investors
Khosla Ventures1 shared
Northpond Ventures1 shared
Cherry Ventures1 shared
Kindred Ventures1 shared
LocalGlobe1 shared
Plural1 shared
APEX Ventures1 shared
Last updated: 16 April 2026